0.283
price up icon0.11%   0.0003
 
loading

Leap Therapeutics Inc Azioni (LPTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
6.06%
16.88
15.92 16.12 17.86 21.25
Operating Income/Loss
6.06%
-16.88
-15.92 -16.12 -17.86 -21.25
Income/Loss From Continuing Operations Before Tax
7.83%
-16.64
-15.44 -15.55 -17.47 -20.13
Income/Loss From Continuing Operations After Tax
7.83%
-16.64
-15.44 -15.43 -18.18 -20.13
Net Income/Loss
7.83%
-16.64
-15.44 -15.43 -18.18 -20.13
Preferred Stock Dividends And Other Adjustments
-
- - - 0.234
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.43%
41.44
41.27 1.2428 41.21 39.12
Diluted Average Shares
0.43%
41.44
41.27 1.2428 41.21 39.12
Basic Earnings Per Share
8.11%
-0.40
-0.37 -0.37 -0.44 -0.52
Diluted Earnings Per Share
8.11%
-0.40
-0.37 -0.37 -0.44 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - 0.234
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):